Literature DB >> 15182094

Erectile dysfunction and cardiovascular disease.

Shane T Russell1, Bijoy K Khandheria, Ajay Nehra.   

Abstract

Cardiovascular disease and erectile dysfunction (ED) are closely interrelated disease processes. Erectile dysfunction reportedly affects 10 million to 20 million men in the United States and more than 100 million men worldwide. Each year, about 500,000 persons in the United States survive a myocardial infarction, and an estimated 11 million have existing cardiovascular disease, making the issue of sexual function and cardiac disease relevant to many patients. We explore the relationship between ED and the presence of cardiovascular disease in the general population. We also review the prevalence and pathophysiological associations of ED and cardiovascular disease. The risks of sexual activity for patients with cardiovascular disease are discussed, as are prevention and treatment strategies for ED in this patient population.

Entities:  

Mesh:

Year:  2004        PMID: 15182094     DOI: 10.4065/79.6.782

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  4 in total

1.  Smoking and erectile dysfunction: findings from a representative sample of Australian men.

Authors:  C Millett; L M Wen; C Rissel; A Smith; J Richters; A Grulich; R de Visser
Journal:  Tob Control       Date:  2006-04       Impact factor: 7.552

Review 2.  Erectile dysfunction: interrelationship with the metabolic syndrome.

Authors:  Glenn Matfin; Ali Jawa; Vivian A Fonseca
Journal:  Curr Diab Rep       Date:  2005-02       Impact factor: 4.810

3.  The cumulative effects of medication use, drug use, and smoking on erectile dysfunction among men who have sex with men.

Authors:  Trevor A Hart; David Moskowitz; Christopher Cox; Xiuhong Li; David G Ostrow; Ron D Stall; Pamina M Gorbach; Michael Plankey
Journal:  J Sex Med       Date:  2012-02-09       Impact factor: 3.802

Review 4.  Lower urinary tract symptoms and erectile dysfunction: epidemiology and treatment in the aging man.

Authors:  Shane Russell; Kevin T McVary
Journal:  Curr Urol Rep       Date:  2005-11       Impact factor: 2.862

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.